Foster Wheeler Eastern Private Limited has been awarded an engineering, procurement, construction management and commissioning services contract by GlaxoSmithKline Biologicals for a new biotechnology production facility in Singapore.
The value of the contract was not disclosed. The engineering and procurement services were included in Foster Wheeler's first-quarter 2007 bookings and the construction management and commissioning services will be included in its third-quarter 2007 bookings.
The facility includes two production buildings, a quality control and administration building, and a utilities building, all on a site of more than 8.8 hectares in Tuas Biomedical Park, in Singapore.
Project to investigate hybrid approach to titanium manufacturing
What is this a hybrid of? Superplastic forming tends to be performed slowly as otherwise the behaviour is the hot creep that typifies hot...